JOANN IRVING: Open Payments
NPI 1821041716 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 24 payments from 10 companies in 2025. Trend: 2023 $297 · 2024 $200 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $139 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Amgen Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Exact Sciences Corporation | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: GEMTESA, EVENITY, Rybelsus, XIFAXAN, Ozempic, Cologuard Collection Kit, RECORLEV, PAXLOVID.
Industry payments across FL — which companies pay providers there.
